Target
Jérôme Delplanque et al.
Monoallelic pathogenic variants in LEPR do not cause obesity
The American Journal of Human Genetics 2024, vol. 111, issue 12
doi: 10.1016/j.ajhg.2024.10.014
Dhanya Ramachandran et al.
Methylation, Gene Expression, and Risk Genotypes at the TERT‐CLPTM1L Locus in Cervical Cancer
Molecular Carcinogenesis 2024, vol. 64, issue 1
doi: 10.1002/mc.23822
Emmanuelle Jousselin et al.
Discordance between mitochondrial, nuclear, and symbiont genomes in aphid phylogenetics: who is telling the truth?
Zoological Journal of the Linnean Society 2024, vol. 201, issue 4
doi: 10.1093/zoolinnean/zlae098
Charles Bobin et al.
Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy
Clinical Cancer Research 2024, vol. 30, issue 15
doi: 10.1158/1078-0432.ccr-24-0753
Rayan Bensenane et al.
Safety of the Breast Cancer Adjuvant Radiotherapy in Ataxia–Telangiectasia Mutated Variant Carriers
Cancers 2024, vol. 16, issue 7
doi: 10.3390/cancers16071417
Yosr Hamdi et al.
A regionally based precision medicine implementation initiative in North Africa:The PerMediNA consortium
Translational Oncology 2024, vol. 44
doi: 10.1016/j.tranon.2024.101940
Antoine Vasseur et al.
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis
Oncogene 2024, vol. 43, issue 16
doi: 10.1038/s41388-024-02986-6
Aurore Pire et al.
Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival
European Journal of Cancer 2024, vol. 200
doi: 10.1016/j.ejca.2024.113583
Lise Folon et al.
Pathogenic, Total Loss-of-Function DYRK1B Variants Cause Monogenic Obesity Associated With Type 2 Diabetes
Diabetes Care 2024, vol. 47, issue 3
doi: 10.2337/dc23-1851
Sarah Meulebrouck et al.
Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas
Diabetologia 2023, vol. 67, issue 2
doi: 10.1007/s00125-023-06035-x